The U.S. Food and Drug Administration approved Tyruko, the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms of...
Morgan Stanley Investment Management, through Morgan Stanley Infrastructure Partners ("MSIP"), and U.S. maritime, energy and logistics solutions leader Crowley announced the creation of a...
Pasternack, an Infinite Electronics brand and a leading provider of RF, microwave and millimeter-wave products, has announced its latest offering of quad-ridge, dual-polarized, broadband gain...
Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, announced that the U.S. Food and Drug Administration (FDA) has granted...
Malwarebytes, a global leader in real-time cyber protection, announced the acquisition of Cyrus, a disruptive innovator in online privacy solutions. This strategic acquisition reinforces Malwarebytes'...
